Consultant Pediatric Intensivist King's College Hospital London
Disclosure(s):
Akash Deep, MD, FRCPCH: No relevant financial relationship(s) to disclose.
Continuous renal replacement therapy (CRRT) is increasingly used in PICUs worldwide. However, there are no consensus guidelines for healthcare professionals to deliver continuous kidney replacement therapy (CKRT) to critically ill children. In this session, speakers will discuss the most common controversies in the delivery of CKRT to children, the current evidence, and best practice recommendations. Speakers will address the timing of initiation, timing of liberation from CKRT, controversies around anticoagulation, quality markers used to assess the efficacy of therapy, and drug alterations while on CRRT.
Learning Objectives:
Describe the controversies of continuous renal replacement therapy (CRRT) provision to children across the entire spectrum of pediatric critical illness, including timing of initiation and liberation from CRRT
Discuss various anticoagulation strategies to achieve adequate filter life with desired efficacy and without unwarranted side effects
Discuss quality dashboard and indicators that help a team review their CRRT service, benchmark against standards, and audit their performance
Discuss drug dosing while on continuous kidney replacement therapy (CKRT)
